CRBN and plasma cell myeloma: In that work, we also revealed that IMiDs can prevent CRBN from ubiquitination and subsequent degradation, leading to the increased CRBN protein level and enhanced CRL4CRBN E3 ligase activity, contributing to the anti-myeloma effect of IMiDs.